Q1 2022 Catalyst Pharmaceuticals Inc Earnings Call Transcript
Greetings, and welcome to Catalyst Pharmaceuticals CPRX First Quarter 2022 Financial Results Conference Call (Operator Instructions) As a reminder, this conference is being recorded.
It is now my pleasure to introduce your host, Ali Grande, CFO of Catalyst Pharmaceuticals. Please go ahead, ma'am.
Good morning, everyone, and thank you for joining our conference call to discuss Catalyst's first quarter 2022 financial results and corporate highlights. Leading the call today is Patrick McEnany, Chairman and Chief Executive Officer. We are also joined by Dr. Steven Miller, our Chief Operating Officer and Chief Scientific Officer; and Jeffrey Del Carmen, our Chief Commercial Officer. Further, for the Q&A session, we'll have Dr. Gary Ingenito, our Chief Medical and Regulatory Officer; and Brian Elsbernd, our Chief Legal and Compliance Officer.
Before we begin, I would like to remind you that in our presentation this morning and in the Q&A session, we will make
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |